|
To take three aspirins per week since at least six months could help towards the prevention of the cancer epithelial of the ovary, the most frequent of the ovarian cancers. Such is the result of an American survey that sustains the thesis according to which a chronic inflammation is at the origin of the development of this cancer. Nevertheless, different inherent limits to this survey don't permit today to recommend the aspirin as means of prevention. Whereas one had already assigned to the aspirin a protective effect against the cancer colorectal, a recent American survey seems to lend him other virtues. its regular and prolonged hold could limit the risks of cancer of the ovary. A protective effectA survey presented at the time of the Yearly Convention of the obstetric oncology Society American driven on 12 329 women seems to attest a tie between the regular and prolonged consumption of aspirin and the reduction of the risk of cancer épithélial of the ovary. Contrary to the previous studies on the same topic, this research achieved under the aegis of the National Institute Health of (NIH) is prospective. During the recruiting period (enters 1985 and 1991), he has been asked the participants for their consumption of aspirin or other analgesics during the four previous weeks. Of the supplementary information on the regular use and on the long term have been collected thanks to questionnaires (1994-1996, 1997-1999). Among this cohort, 68 women have been identified like attacks of a cancer ovarian épithélial. While comparing the group of sick women to the other, the researchers isolated the influence of their consumption of aspirin of the other factors of risk knew as the menopause, age, the ethnic origin, the level of education, the indication of bodily mass, age at the time of the first pregnancy, the contraception, the tobacco addiction or a domestic history of cancer. Of ampler necessary studiesResults: if the episodic use of aspirin doesn't seem to have no influence, the women who take the aspirin during at least six months, at least three times per week, have 40% of risk of less to develop a cancer of this type in relation to those that don't use some. However, before adding a new virtue to this hundred-year-old compound of ampler studies will be necessary. Indeed, the number of included women in the remained test reduces. And no information is available concerning the quantity and the reason of the aspirin consumption. Besides, this compound is not deprived of secondary effects, it can increase the risk of bleeding, especially to the level of the stomach and the intestine. Responsible of these works, Akhmedkhanovs and his colleagues participate in other studies in the setting of the program NYU Women's Health Study aiming to determine the possible protective power of the aspirin against the cancer of the lung and the uterus. 2009-02-18 
|
